Latest News about MRTX
Recent news which mentions MRTX
Why Shares of Mirati Therapeutics Are Jumping Wednesday
August 09, 2023
Tickers
MRTX
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 09, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
From Benzinga
From Benzinga
British billionaire owner of Tottenham football club charged with ‘brazen’ insider trading
July 25, 2023
From MarketWatch
Stocks That Hit 52-Week Lows On Friday
July 21, 2023
From Benzinga
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 21, 2023
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
From Benzinga
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 25, 2023
From Benzinga
Mirati's Sitravatinib Flunks Phase 3 Combo Therapy Study In Type Of Lung Cancer Setting
May 25, 2023
From Benzinga
Snowflake, American Eagle, Digital Turbine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 25, 2023
From Benzinga
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
From Benzinga
Why Shares of Zai Lab Soared This Week
January 05, 2023
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
SKLZ Stock Alert: Will Skillz Shares Get Delisted?
December 22, 2022
From InvestorPlace
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today?
December 22, 2022
From InvestorPlace
Why Is ProQR (PRQR) Stock Up 83% Today?
December 22, 2022
From InvestorPlace
Why Is Mirati Therapeutics (MRTX) Stock Up Today?
December 22, 2022
From InvestorPlace
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
December 15, 2022
From Benzinga
SVB Leerink Maintains Outperform Rating for Mirati Therapeutics: Here's What You Need To Know
December 14, 2022
Tickers
MRTX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
From Benzinga
Tesla To $235? Here Are 10 Other Price Target Changes For Wednesday
December 14, 2022
From Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
From Benzinga
Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting
December 13, 2022
Tickers
MRTX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.